Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial

NCT00675025 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
117
Enrollment
INDUSTRY
Sponsor class

Stopped Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns.

Conditions

Interventions

Sponsor

Eisai Inc.

Collaborators